JUNE PHARMA LIMITEDActive

Company number 10197232Private limited companyIncorporated 2016

Key figures

£312,722-17.8%
Net assets 2025/26
+5.9%
Average annual growth 2019/20–2025/26
0200 k400 k600 k2019/202020/212021/222022/232023/242024/252025/26

Like most small UK companies, JUNE PHARMA LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0250 k500 k750 k2019/202020/212021/222022/232023/242024/252025/26
Filed accounts2019/20–2025/26
2021/222022/232023/242024/252025/26
Total assets502,732627,498673,919478,933406,279
Total liabilities30,655103,295141,74298,59093,557
Net assets / total equity472,077524,203532,177380,343312,722
Average number of employees22212

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: JUNE PHARMA LIMITED

Company

JUNE PHARMA LIMITED is a private limited company registered with Companies House under company number 10197232. It was incorporated on 24 May 2016. Its status is active. The registered office is in London (W4). Its nature of business (SIC 2007) is management consultancy activities other than financial management (70229).

Accounts

The latest accounts in the database are for 2025/26 (period ending 31 May 2026); the company files micro-entity accounts. Net assets were £312,722, down 17.8% on the previous year. Total assets were £406,279 and total liabilities £93,557. The company had an average of 2 employees. Figures are available for 7 financial years (2019/20–2025/26).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 29 Feb 2028. The next confirmation statement is due by 6 Jun 2027.